+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidiabetic"

From
US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026 - Product Thumbnail Image

US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026

  • Report
  • August 2021
  • 50 Pages
  • United States
From
Global Markets for Diabetes Therapeutics and Diagnostics - Product Thumbnail Image

Global Markets for Diabetes Therapeutics and Diagnostics

  • Report
  • August 2023
  • 336 Pages
  • Global
From
From
From
From
Loading Indicator

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides. Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more